Nxstage Medical, Inc. (NXTM)

[surf1944]

7:19AM Nxstage Medical reports EPS in-line, beats on revs; guides Q3 EPS in-line, revs above consensus; guides FY11 EPS in-line, revs in-line (NXTM) 16.96 : Reports Q2 (Jun) loss of $0.10 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.10); revenues rose 22.3% year/year to $53.8 mln vs the $51.1 mln consensus. Co issues mixed guidance for Q3, sees EPS of ($0.09-0.11) vs. ($0.09) Capital IQ Consensus Estimate; sees Q3 revs of $53.5-54.5 mln vs. $52.58 mln Capital IQ Consensus Estimate. Co issues in-line guidance for FY11, sees EPS of ($0.36-0.43) vs. ($0.37) Capital IQ Consensus Estimate; sees FY11 revs of $210-215 mln vs. $211.16 mln Capital IQ Consensus Estimate.